The University of Cambridge has begun a second phase of canine trials of PharmAust’s promising anti-cancer drug, taking it a step closer to widespread availability for pet owners. The trial will also provide information on the potential for the Perth-based company’s new drug as a breakthrough cancer treatment for humans.
19/09/2016 - 22:39
New trials of PharmAust cancer drug underway at Cambridge Uni
By Matt Birney
19/09/2016 - 22:39
Related Data & Insights
-
-
Rank Company Revenue 128th PharmAust $3.8m 129th ResApp Health $3.8m 130th Emyria $3.8m 132nd Botanix Pharmaceuticals $3.8m 133rd Volt Power Group $3.6m 200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
05 Feb 2024
Board Moves February 5, 2024
28 Aug 2023
Board Moves August 28, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX